DocGo Awarded 5-Year Contract with South Central Ambulance Service in the UK

DocGo Inc. (NASDAQ:DCGO), a leading provider of technology-enabled mobile health services, announced today that its UK-based subsidiary, Ambulnz Community Partners, has been awarded a 5-year contract to provide emergency and urgent ambulance services for South Central Ambulance Service NHS Foundation Trust.

Natalie Lamb, Managing Director of Ambulnz Community Partners, commented: "This is a very proud moment for our group as we continue to expand our portfolio and footprint of higher acuity services in line with our organizational strategy across Berkshire, Oxfordshire, and Buckinghamshire."

Ms. Lamb added: "This is the first time SCAS has awarded a 5-year contract to a private provider and we are thrilled to have been selected as one of their three regional providers. We are immensely grateful to all our staff and leadership for their unwavering commitment over the past 5 years; without them this would not have been possible."

The services under the contract will include 16 ambulances per day providing paramedic-led frontline urgent and emergency response. Mobilization is set to begin in October of this year. The contract is part of the Ambulnz Community Partners expansion into offering services for higher acuity care and reflects its continued growth across the UK.

The company is also currently providing medical transport services for North East Ambulance Service NHS Foundation Trust; North West Ambulance Service NHS Trust; East of England Ambulance Service NHS Trust; and Yorkshire Ambulance Service NHS Trust as well as other organizations in the region.

Proudly owned by DocGo, Ambulnz Community Partners UK operations include 15 locations, and approximately 700 operational staff members, and 350 ambulances.

About DocGo

DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo disrupts the traditional four-wall healthcare system by providing high quality, highly affordable care to patients where and when they need it. DocGo's proprietary, AI-powered technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit docgo.com.

Forward-Looking Statements

This announcement contains forward-looking statements (including within the meaning of Section 21E of the U.S. Securities Exchange Act of 1934, as amended, and Section 27A of the U.S. Securities Act of 1933, as amended) concerning DocGo. These statements include, but are not limited to, statements that address our expected future business, financial performance and guidance and statements about (i) our plans, objectives and intentions with respect to future operations, services and products, including our transition to non-COVID related services, geographic expansion, rapid normalization initiative, new and existing contracts and backlog, serviceable patient population, M&A activity, workforce growth, leadership transition, cash position and share repurchase program, (ii) our competitive position and opportunities, including our addressable market opportunities, expected demand for our products and our ability to realize the benefits from our operating model, and (iii) other statements identified by words such as "may", "will", "expect", "intend", "plan", "potential", "believe", "seek", "could", "estimate", "judgment", "targeting", "should", "anticipate", "predict" "project", "aim", "goal", "outlook", "guidance", "design" and similar words, phrases or expressions. These forward-looking statements are based on management's current expectations and beliefs, as well as assumptions made by, and information currently available to, management, and current market trends and conditions. Forward-looking statements inherently involve risks and uncertainties, many of which are beyond our control, and which may cause actual results to differ materially from those contained in our forward-looking statements. Accordingly, you should not place undue reliance on such statements. Particular uncertainties that could materially affect current or future results include possible accounting adjustments made in the process of finalizing reported financial results; any risks associated with global macroeconomic and geopolitical conditions and concerns, including rising interest rates, the inflationary environment, the potential recessionary environment, regional conflict and tensions, financial institution instability and the prospect of a shutdown of the U.S. federal government; the effects of global outbreaks of pandemics or contagious diseases or fear of such outbreaks, such as the COVID-19 coronavirus pandemic; competitive pressures; availability of healthcare professionals; changes in the cost of labor; pricing declines; rates of growth in our target markets; our ability to improve gross margins; cost-containment measures; loss of major customers; legislative and regulatory actions; the impact of legal proceedings and compliance risks; the impact on our business and reputation in the event of information technology system failures, network disruptions, cyber-attacks, or losses or unauthorized access to, or release of, confidential information; and the ability of the Company to comply with laws and regulations regarding data privacy and protection. We undertake no intent or obligation to publicly update or revise any of these forward-looking statements, whether as a result of new information, future events or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231009409882/en/